WallStreetZenWallStreetZen

NASDAQ: RGLS
Regulus Therapeutics Inc Stock Ownership - Who owns Regulus Therapeutics?

OverviewForecastEarningsDividendOwnership

Insider buying vs selling

Have Regulus Therapeutics Inc insiders been buying or selling?
Buy
Sell
NameRoleDateSharesPriceValue
Stelios PapadopoulosDirector2024-03-14250,000$1.60
$400.00kBuy
Christopher Ray AkerSr. VP General Counsel2024-01-185,468$1.19
$6.51kSell
Crispina CalsadaChief Financial Officer2024-01-185,468$1.19
$6.51kSell
Joseph P. HaganChief Executive Officer2024-01-1814,580$1.19
$17.36kSell

1 of 1

RGLS insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when RGLS insiders and whales buy or sell their stock.

RGLS Shareholders

What type of owners hold Regulus Therapeutics Inc stock?
Institutional
Insider
Retail
NameHoldSharesValueType
Chetan Puttagunta16.79%10,989,010$23.41MInsider
Jon Sakoda16.79%10,989,010$23.41MInsider
Ravi Viswanathan16.79%10,989,010$23.41MInsider
Carmen Chang12.99%8,503,510$18.11MInsider
Paul Edward Walker12.99%8,503,510$18.11MInsider
Mohamad Makhzoumi12.99%8,503,510$18.11MInsider
Forest Baskett12.99%8,503,510$18.11MInsider
Ali Behbahani12.99%8,503,510$18.11MInsider
Peter W. Sonsini12.99%8,503,510$18.11MInsider
Joshua Makower12.99%8,503,510$18.11MInsider

1 of 3

RGLS vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
RGLS5.87%94.13%Net BuyingNet Buying
ZURA27.84%72.16%Net Selling
MDWD27.28%0.00%
CLLS17.66%0.00%
CRVO0.47%99.53%
View Top Biotech Stocks

Regulus Therapeutics Stock Ownership FAQ

Who owns Regulus Therapeutics?

Regulus Therapeutics (NASDAQ: RGLS) is owned by 16.98% institutional shareholders, 272.41% Regulus Therapeutics insiders, and 0.00% retail investors. Chetan Puttagunta is the largest individual Regulus Therapeutics shareholder, owning 10.99M shares representing 16.79% of the company. Chetan Puttagunta's Regulus Therapeutics shares are currently valued at $24.18M.

If you're new to stock investing, here's how to buy Regulus Therapeutics stock.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.